• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Resmed Inc (NY: RMD )

    206.20 UNCHANGED
    Streaming Delayed Price Updated: 7:00 PM EDT, Jul 24, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 206.20
    Bid (Size) 200.00 (10)
    Ask (Size) 220.00 (1)
    Prev. Close 206.20
    Today's Range 206.20 - 206.20
    52wk Range 132.24 - 229.97
    Shares Outstanding 146,234,244
    Dividend Yield 0.93%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    What 6 Analyst Ratings Have To Say About ResMed
    Via Benzinga

    Performance

    YTD
    +20.04%
    +20.04%
    1 Month
    +13.17%
    +13.17%
    3 Month
    +12.20%
    +12.20%
    6 Month
    +20.04%
    +20.04%
    1 Year
    -6.27%
    -6.27%

    More News

    Read More
    Looking Into ResMed's Recent Short Interest
    Via Benzinga
    Stock Market News From Amazon, Nike, McCormick, and More
    Via The Motley Fool
    Falling Knives: 3 Stocks Getting the Cold Shoulder From Analysts
    Via InvestorPlace
    $1000 Invested In This Stock 15 Years Ago Would Be Worth $9,600 Today
    Via Benzinga
    Is NYSE:RMD a Good Fit for Dividend Investing?
    Via Chartmill
    Beyond The Numbers: 6 Analysts Discuss ResMed Stock
    Via Benzinga
    ResMed to Report Fourth Quarter Fiscal 2024 Earnings on August 1, 2024
    From ResMed Inc.
    Via GlobeNewswire
    How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
    Via The Motley Fool
    Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
    Via MarketBeat
    Exposures Product Safety
    (RMD) - Analyzing ResMed's Short Interest
    Via Benzinga
    If You Invested $1000 In This Stock 15 Years Ago, You Would Have $11,000 Today
    Via Benzinga
    Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
    Via InvestorPlace
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Why ResMed Shares Are Trading Lower Monday
    Via Benzinga
    ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
    Via Benzinga
    Semiconductor, Nvidia Woes Deepen; Nasdaq 100 Slips, Dow Rallies; Bitcoin Sinks To $60,400: What's Driving Markets Monday?
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Stocks Mixed As Investors Take Big Tech Profits
    Via Talk Markets
    Eli Lilly's Weight-Loss Drug Takes Down ResMed, Inspire Medical — Again
    Via Investor's Business Daily
    Nasdaq Futures Slip As Nvidia Sell-Off Continues, S&P 500 Futures Hold Up: Analyst Says 'Valuations Will Go Parabolic And It Will Be A Perfect Time To Sell'
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Elliott Wave Technical Forecast: Unlocking ASX Trading Success: ResMed Inc
    Via Talk Markets
    PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia
    From ResMed Inc.
    Via GlobeNewswire
    Stryker Stock Sees RS Rating Treks Higher To 71
    Via Investor's Business Daily
    $100 Invested In ResMed 20 Years Ago Would Be Worth This Much Today
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.